Effects of Immunomodulation Therapy on Anti-rhGAA Immune Response in Children with Pompe Disease Receiving rhGAA Enzyme Replacement Therapy
Purpose
The purpose of this research study is to determine the effect(s) of medications that alter the immune system on anti-rhGAA immune response in Pompe patients receiving rhGAA enzyme replacement therapy (ERT), and to understand the immune response in Pompe children treated with ERT that do not make antibodies against ERT. In addition, the study is being conducted to determine whether treating Pompe Disease with medications that affect the immune system has any effect on the overall health or disease progression in patients with Pompe disease.
Keywords
Children, Anti-rhGAA Immune Response, Pompe Disease, rhGAA Enzyme Replacement Therapy (ERT), MYOZYMEPrincipal Investigator
Barry J Byrne, M.D.Department
Contact Information
Begin a new search for other research studies
Studies listed on this site have been approved by a UF Institutional Review Board (IRB), which works to ensure the welfare and rights of research participants as required by federal regulations. Study listings are provided by the UF Clinical and Translational Science Institute in collaboration with UF research teams and the UF IRBs.